ESTRO35 Programme Book

> Are the encouraging SABR results for NSCLC reproducible outside of pioneering academic institutions? C. Peedell (UK), E. Aynsley, D. Shakespeare, J. Green, P. Summers, J. Reynolds, K. Burke, H. Bayles, C. Huntley, N. Richmond > Changes in pulmonary function after single-fraction carbon-ion radiotherapy for stage I NSCLC W. Takahashi (Japan), N. Yamamoto, M. Nakajima, M. Karube, H. Yamashita, K. Nakagawa, H. Tsuji, T. Kamada > Radiotherapy as adjuvant or definitive treatment method in thymic tumours A. Napieralska (Poland), L. Miszczyk > Do higher doses of palliative radiotherapy still prolong survival in stage III/IV NSCLC? A. Price, K. MacLennan (UK), S. Campbell, S. Erridge, F. Little, T. Evans > Differential diagnosis between toxicity and recurrence after SBRT in early stage inoperable NSCLC R. Frakulli (Italy), F. Salvi, D. Balestrini, M. Palombarini, S. Cammelli, G. Macchia, M. Zompatori, A.G. Morganti, G. Frezza > Effect of overall treatment time in dose escalatation for radiotherapy of NSCLC. BED-time analysis J. Cabrera (Spain), A. Torres, A. Ruiz, A. Corbacho, M.A. Gonzalez, J. Quiros, F. Ropero, J. Muñoz > Salvage radiotherapy for locoregionally recurrent non-small cell lung cancer after resection E. Kim (Republic of Korea), J.S. Kim > Utilisation of new functional imaging in NSCLC radiotherapy: Can we use DW-MRI? M. Al Daly (Egypt), R. Hani, M. Fayec, S. Talima, H. Khafagy, M. Kmal, M. Hassan > Postoperative hypofractionated radiotherapy of non-small cell lung cancer: pattern of the relapses V.M. Sotnikov (Russian Federation), V.A. Solodkiy, V.M. Kcharchenko, G.A. Panshin, V.D. Chhikvadze, S.D. Trocenko, A.A. Morgunov

EP-1212

ELECTRONIC POSTERS

EP-1213

EP-1214

EP-1215

EP-1216

EP-1217

EP-1218

EP-1219

EP-1220

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

POSTERS AND ELECTRONIC POSTERS | PROGRAMME AND EXHIBITION GUIDE

232